FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2-positive breast cancer cells.

about

FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2-positive breast cancer cells.

Item

http://www.wikidata.org/entity/Q41623719

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

FEN1 knockdown improves trastu ...... -positive breast cancer cells.

@en

type

Item

label

FEN1 knockdown improves trastu ...... -positive breast cancer cells.

@en

prefLabel

FEN1 knockdown improves trastu ...... -positive breast cancer cells.

@en

P1476

FEN1 knockdown improves trastu ...... 2-positive breast cancer cells

@en

P2093

Chen-Yang Zhao

http://www.w3.org/2001/XMLSchema#string

Chun-Lei Zheng

http://www.w3.org/2001/XMLSchema#string

Ke-Zuo Hou

http://www.w3.org/2001/XMLSchema#string

Lu Xu

http://www.w3.org/2001/XMLSchema#string

Xiaofang Che

http://www.w3.org/2001/XMLSchema#string

Xiu-Juan Qu

http://www.w3.org/2001/XMLSchema#string

Xue Zeng

http://www.w3.org/2001/XMLSchema#string

Yuee Teng

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

FEN1 is overexpressed in testis, lung and brain tumors

Flap endonuclease 1: a central component of DNA metabolism

Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers

Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis

HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells

An evolutionarily conserved synthetic lethal interaction network identifies FEN1 as a broad-spectrum target for anticancer therapeutic development

P304

3265-3272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4873

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yunpeng Liu

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28912877

http://www.w3.org/2001/XMLSchema#string

P932

5585749

http://www.w3.org/2001/XMLSchema#string